Get started
Author

B. Schipman

Observed names: Benjamin Schipman, SCHIPMAN, Benjamin, Schipman, Benjamin
ORCID: 0009-0005-0872-5959
Observed ORCID: 0009-0005-0872-5959
OpenAlex ID: A5034900992
Management of Patients with Head and Neck Tumours Presenting at Diagnosis with a Synchronous Second Cancer at Another Anatomic Site
2010 · P. Graff, B. Schipman, et al. · Clinical Oncology · 20
Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results
2016 · Valentine Guimas, Jihane Boustani, et al. · Drugs & Aging · 18
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis
2023 · C. Yuste, V. Passerat, et al. · Clinical and Translational Radiation Oncology · 9
PDF
Salvage radiotherapy with volumetric modulated arc therapy (VMAT) for recurrent prostate cancer after high-intensity focused ultrasound (HIFU): A large French retrospective series and literature review
2024 · Jérémy Baude, Charles Teyssier, et al. · Radiotherapy and Oncology · 8
Efficacy of Auricular Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: A Case Series of 73 Cases
2021 · Erika Viel, David Truong, et al. · Medical Acupuncture · 8
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib
2024 · J. Chamois, A.L. Septans, et al. · Clinical and Translational Radiation Oncology · 6
PDF
Efficiency of auricular acupuncture in climacteric symptoms after cancer treatments
2016 · E. Viel, A. Vanoli, et al. · Climacteric · 5
Recent advances in the treatment of localized rectal cancer
2008 · Jean-François Bosset, France Nguyen, et al. · Current Oncology Reports · 5
Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers
2023 · F. Huguet, O. Riou, et al. · Cancer/Radiothérapie · 3
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
2026 · Hugo Corda, Audrey Blanc-Lapierre, et al. · Radiotherapy and Oncology · 2
Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique
2025 · Charles Raynaud, Maria Jolnerovski, et al. · Cancer/Radiothérapie · 2
Rectal cancer radiotherapy: 2025 update
2025 · Alice Blache, Marina Jolnerowski, et al. · Cancer/Radiothérapie · 2
Quel apport de la modulation d’intensité pour la radiothérapie des cancers du rectum ?
2022 · Y. Pointreau, J. Moreau, et al. · Cancer/Radiothérapie · 2
Chimioradiothérapie préopératoire du cancer du rectum : expérience d’un centre
2015 · N. Lescut, A. Lepinoy, et al. · Cancer/Radiothérapie · 2
Real-world evidence for preoperative use of (chemo)radiotherapy with intensity modulation for locally advanced rectal cancer by the Colib French group
2025 · Yoann Pointreau, Nicolas Blanchard, et al. · Cancer/Radiothérapie · 1
Metastasis-directed ablative radiotherapy in castrate-resistant oligometastatic prostate cancer: A retrospective study of 8 high-volume French centers from the COLib (Cercle des Oncologues Libéraux).
2023 · Jerome Chamois, Anne-Lise Septans, et al. · Journal of Clinical Oncology · 1
Capecitabin (Cap) compared with flurorouracil (5FU)-leucovorin (LV) as concurrent chemotherapy for preoperative chemoradiation (preop CRT) in rectal cancers: A retrospective study.
2011 · B. Schipman, T. Nguyen, et al. · Journal of Clinical Oncology · 1
Chimioradiothérapie des cancers du rectum
2007 · F. Nguyen, M. Bosset, et al. · ONCOLOGIE · 1
Study Protocol of OLIGOPELVIS 2–GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
2026 · Quentin Josset, Audrey Blanc-Lapierre, et al. · European Urology Oncology
2263 Early Toxicity of elective nodal RT for Oligorecurrent Pelvic/Paraaortic nodes in Prostate Cancer: a randomised phase 3 trial OLIGOPELVIS-2/GETUG P12.
2026 · Hugo Corda, Audrey Blanc-Lapierre, et al. · Radiotherapy and Oncology
Machine Learning-Based Prediction of Overall Survival After Lung SBRT Using Clinical, Dosimetric, and Radiomics Features: a multicenter study
2026 · Camille Invernizzi, Pierre-Louis Benveniste, et al. · Research Square
PDF
7 Phantom LEGO® Vs CT4D
2018 · P. Lamoly, J.Y. Gosselin, et al. · Physica Medica
Facteurs de risques de toxicité urinaire et digestive des patients traités initialement par radiothérapie externe avec modulation d’intensité 80 gy pour cancer de prostate. Une étude prospective mono-opérateur
2018 · A. Schneider, B. Schipman · The French Journal of Urology
Facteurs de risques de toxicité urinaire et digestive après radiothérapie prostatique (IMRT-VMAT®) adjuvante/rattrapage après prostatectomie : étude prospective mono-opérateur
2017 · A. Schneider, B. Schipman · The French Journal of Urology
Étude prospective d’identification des facteurs de risques de toxicité de la radiothérapie adjuvante et de rattrapage du cancer de prostate après prostatectomie radicale : expérience de la modulation d’intensité par arcthérapie
2017 · A. Schneider, B. Schipman · Cancer/Radiothérapie
Works count: 36
Citation count: 96
H-index: 6
I10-index: 2
Year
Topic
Type